SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ux9'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1H8S_A_AICA1000_1
(MUTANT AL2 6E7P9G)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		6 / 12 TYR B  39
GLN B  92
PHE B 103
VAL B 171
ALA B 231
TRP B 243
 None
 0.74A 1h8sA-3ux9B:
27.3		 1h8sA-3ux9B:
48.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.12A 1zzrA-3ux9B:
undetectable
1zzrB-3ux9B:
undetectable		 1zzrA-3ux9B:
21.28
1zzrB-3ux9B:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.14A 1zzrA-3ux9B:
undetectable
1zzrB-3ux9B:
undetectable		 1zzrA-3ux9B:
21.28
1zzrB-3ux9B:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.12A 1zzuA-3ux9B:
undetectable
1zzuB-3ux9B:
undetectable		 1zzuA-3ux9B:
21.28
1zzuB-3ux9B:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.11A 1zzuA-3ux9B:
undetectable
1zzuB-3ux9B:
undetectable		 1zzuA-3ux9B:
21.28
1zzuB-3ux9B:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)		 3ux9 INTERFERON
ALPHA-1/13
(Homo
sapiens) 		5 / 12 SER A 151
ILE A 148
PHE A  36
ALA A 119
GLU A  59
 None
 0.76A 2j0dA-3ux9A:
undetectable		 2j0dA-3ux9A:
16.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OLD_B_IPHB2001_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 TYR B  39
PRO B  47
TYR B  90
TYR B 229
 None
 0.73A 2oldA-3ux9B:
21.2
2oldB-3ux9B:
21.3		 2oldA-3ux9B:
38.26
2oldB-3ux9B:
38.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.15A 3dqrA-3ux9B:
undetectable
3dqrB-3ux9B:
undetectable		 3dqrA-3ux9B:
21.18
3dqrB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.17A 3dqrA-3ux9B:
undetectable
3dqrB-3ux9B:
undetectable		 3dqrA-3ux9B:
21.18
3dqrB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK6_B_HCZB800_1
(GLUTAMATE RECEPTOR 2)		 3ux9 INTERFERON
ALPHA-1/13
SCFV ANTIBODY
(Homo
sapiens) 		5 / 10 LEU B 213
ILE B 185
SER A  27
SER B 165
GLY B 187
 None
 1.46A 3ik6B-3ux9B:
undetectable
3ik6E-3ux9B:
undetectable		 3ik6B-3ux9B:
21.33
3ik6E-3ux9B:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.07A 3jx2A-3ux9B:
undetectable
3jx2B-3ux9B:
undetectable		 3jx2A-3ux9B:
21.18
3jx2B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.12A 3jx2A-3ux9B:
undetectable
3jx2B-3ux9B:
undetectable		 3jx2A-3ux9B:
21.18
3jx2B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.14A 3jx3A-3ux9B:
undetectable
3jx3B-3ux9B:
undetectable		 3jx3A-3ux9B:
21.18
3jx3B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.09A 3jx3A-3ux9B:
undetectable
3jx3B-3ux9B:
undetectable		 3jx3A-3ux9B:
21.18
3jx3B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.14A 3jx4A-3ux9B:
undetectable
3jx4B-3ux9B:
undetectable		 3jx4A-3ux9B:
21.18
3jx4B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.11A 3jx5A-3ux9B:
undetectable
3jx5B-3ux9B:
undetectable		 3jx5A-3ux9B:
21.18
3jx5B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.12A 3jx5A-3ux9B:
undetectable
3jx5B-3ux9B:
undetectable		 3jx5A-3ux9B:
21.18
3jx5B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.03A 3jx6A-3ux9B:
undetectable
3jx6B-3ux9B:
undetectable		 3jx6A-3ux9B:
21.18
3jx6B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.07A 3jx6A-3ux9B:
undetectable
3jx6B-3ux9B:
undetectable		 3jx6A-3ux9B:
21.18
3jx6B-3ux9B:
21.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3KDM_H_TESH226_1
(IMMUNOGLOBULIN HEAVY
CHAIN
IMMUNOGLOBULIN LIGHT
CHAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		5 / 9 SER B 169
TRP B 181
ALA B 184
TYR B 193
MET B 240
 None
 0.75A 3kdmH-3ux9B:
14.2
3kdmL-3ux9B:
21.4		 3kdmH-3ux9B:
66.47
3kdmL-3ux9B:
39.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.05A 3nljA-3ux9B:
undetectable
3nljB-3ux9B:
undetectable		 3nljA-3ux9B:
21.18
3nljB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.06A 3nljA-3ux9B:
undetectable
3nljB-3ux9B:
undetectable		 3nljA-3ux9B:
21.18
3nljB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.08A 3nlpA-3ux9B:
undetectable
3nlpB-3ux9B:
undetectable		 3nlpA-3ux9B:
21.18
3nlpB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.11A 3nlpA-3ux9B:
undetectable
3nlpB-3ux9B:
undetectable		 3nlpA-3ux9B:
21.18
3nlpB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 8 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.07A 3nlqA-3ux9B:
undetectable
3nlqB-3ux9B:
undetectable		 3nlqA-3ux9B:
21.18
3nlqB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.13A 3nlqA-3ux9B:
undetectable
3nlqB-3ux9B:
undetectable		 3nlqA-3ux9B:
21.18
3nlqB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.08A 3nlrA-3ux9B:
undetectable
3nlrB-3ux9B:
undetectable		 3nlrA-3ux9B:
21.18
3nlrB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 8 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.11A 3nlrA-3ux9B:
undetectable
3nlrB-3ux9B:
undetectable		 3nlrA-3ux9B:
21.18
3nlrB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.12A 4cx3A-3ux9B:
undetectable
4cx3B-3ux9B:
undetectable		 4cx3A-3ux9B:
21.18
4cx3B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.11A 4cx3A-3ux9B:
undetectable
4cx3B-3ux9B:
undetectable		 4cx3A-3ux9B:
21.18
4cx3B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.14A 4cx4A-3ux9B:
undetectable
4cx4B-3ux9B:
undetectable		 4cx4A-3ux9B:
21.18
4cx4B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.11A 4cx4A-3ux9B:
undetectable
4cx4B-3ux9B:
undetectable		 4cx4A-3ux9B:
21.18
4cx4B-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K17_B_OHBB701_0
(LEUCINE-RICH
REPEAT-CONTAINING
PROTEIN 16A)		 3ux9 INTERFERON
ALPHA-1/13
(Homo
sapiens) 		4 / 5 GLU A 142
ARG A 145
PRO A  26
SER A  27
 None
 1.44A 4k17B-3ux9A:
undetectable		 4k17B-3ux9A:
13.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ACL_A_SASA1111_1
(MCG)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		5 / 7 TYR B  35
SER B  37
TYR B  39
TYR B  52
PRO B  58
 None
 0.78A 5aclA-3ux9B:
21.1		 5aclA-3ux9B:
31.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADD_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.07A 5addA-3ux9B:
undetectable
5addB-3ux9B:
undetectable		 5addA-3ux9B:
21.18
5addB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADE_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.06A 5adeA-3ux9B:
undetectable
5adeB-3ux9B:
undetectable		 5adeA-3ux9B:
21.18
5adeB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 VAL B 111
ARG B  64
VAL B  20
GLU B  86
 None
 1.10A 5g0pA-3ux9B:
undetectable
5g0pB-3ux9B:
undetectable		 5g0pA-3ux9B:
21.18
5g0pB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3ux9 SCFV ANTIBODY
(Homo
sapiens) 		4 / 7 GLU B  86
VAL B 111
ARG B  64
VAL B  20
 None
 1.13A 5g0pA-3ux9B:
undetectable
5g0pB-3ux9B:
undetectable		 5g0pA-3ux9B:
21.18
5g0pB-3ux9B:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KC4_E_RBFE201_2
(RIBOFLAVIN
TRANSPORTER RIBU)		 3ux9 INTERFERON
ALPHA-1/13
(Homo
sapiens) 		3 / 3 LYS A  51
ASP A  44
ILE A 117
 None
 0.69A 5kc4E-3ux9A:
undetectable		 5kc4E-3ux9A:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUG_A_VIVA301_1
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 3ux9 INTERFERON
ALPHA-1/13
(Homo
sapiens) 		3 / 3 SER A 151
SER A 155
PHE A 124
 None
 0.90A 5mugA-3ux9A:
undetectable		 5mugA-3ux9A:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZWR_B_9KLB402_0
(EST-Y29)		 3ux9 INTERFERON
ALPHA-1/13
(Homo
sapiens) 		5 / 12 SER A 151
TYR A 123
PHE A 124
ILE A 127
LEU A  67
 None
 1.21A 5zwrB-3ux9A:
undetectable		 5zwrB-3ux9A:
18.55